Davide Matino

2.3k total citations · 1 hit paper
66 papers, 806 citations indexed

About

Davide Matino is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Davide Matino has authored 66 papers receiving a total of 806 indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Hematology, 13 papers in Molecular Biology and 10 papers in Genetics. Recurrent topics in Davide Matino's work include Hemophilia Treatment and Research (48 papers), Platelet Disorders and Treatments (14 papers) and Blood Coagulation and Thrombosis Mechanisms (10 papers). Davide Matino is often cited by papers focused on Hemophilia Treatment and Research (48 papers), Platelet Disorders and Treatments (14 papers) and Blood Coagulation and Thrombosis Mechanisms (10 papers). Davide Matino collaborates with scholars based in Canada, Italy and United States. Davide Matino's co-authors include Giancarlo Castaman, Francesca Fallarino, Alfonso Iorio, Maria Teresa Pallotta, Ciriana Orabona, Ursula Grohmann, Paolo Puccetti, Marco Gargaro, Antonio Macchiarulo and Giada Mondanelli and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Davide Matino

59 papers receiving 792 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A

2023 100 citations Barbara A. Konkle, Johannes Oldenburg et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Davide Matino Canada	16	432	222	107	92	86	66	806
Morteza Bagheri Iran	13	60 0.1×	133 0.6×	40 0.4×	112 1.2×	44 0.5×	64	629
Nada Starčević Čizmarević Croatia	14	120 0.3×	120 0.5×	78 0.7×	85 0.9×	13 0.2×	37	539
Anne M. Bakken Norway	8	161 0.4×	114 0.5×	70 0.7×	23 0.3×	10 0.1×	16	451
Carella Am Italy	16	572 1.3×	116 0.5×	199 1.9×	115 1.3×	4 0.0×	65	943
Sara Zumerle Italy	8	109 0.3×	121 0.5×	84 0.8×	85 0.9×	4 0.0×	11	683
Sali Usher Israel	11	141 0.3×	70 0.3×	88 0.8×	32 0.3×	6 0.1×	20	480
Ji‐Min Kim South Korea	16	94 0.2×	139 0.6×	13 0.1×	100 1.1×	11 0.1×	40	607
Denise Lowe United States	14	29 0.1×	100 0.5×	45 0.4×	62 0.7×	29 0.3×	26	485
Dondra O'Neill United States	7	52 0.1×	108 0.5×	60 0.6×	21 0.2×	19 0.2×	8	522
Enrico Brignardello Italy	17	53 0.1×	137 0.6×	37 0.3×	19 0.2×	5 0.1×	34	797

Countries citing papers authored by Davide Matino

Since Specialization

Citations

This map shows the geographic impact of Davide Matino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davide Matino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davide Matino more than expected).

Fields of papers citing papers by Davide Matino

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Davide Matino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davide Matino. The network helps show where Davide Matino may publish in the future.

Co-authorship network of co-authors of Davide Matino

This figure shows the co-authorship network connecting the top 25 collaborators of Davide Matino. A scholar is included among the top collaborators of Davide Matino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Davide Matino. Davide Matino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Matino, Davide, Andrew Palladino, Carrie Turich Taylor, et al.. (2025). Marstacimab prophylaxis in hemophilia A/B without inhibitors: results from the phase 3 BASIS trial. Blood. 146(14). 1654–1663. 3 indexed citations

Matino, Davide, Suchitra S. Acharya, Carrie Turich Taylor, et al.. (2025). Efficacy and safety of marstacimab prophylaxis in hemophilia A/B with inhibitors: results from the phase 3 BASIS trial. Blood. 147(9). 920–931.

Kavaklı, Kaan, Adam Cuker, Laurent Frenzel, et al.. (2025). Health-related quality of life in adults with hemophilia B after gene therapy with fidanacogene elaparvovec: results from the BENEGENE-2 trial. Journal of Thrombosis and Haemostasis. 24(1). 132–145.

Leavitt, Andrew D., Kaan Kavaklı, Laurent Frenzel, et al.. (2024). Efficacy and Safety of Giroctocogene Fitelparvovec in Adults with Moderately Severe to Severe Hemophilia Α: Primary Analysis Results from the Phase 3 ΑFFINE Gene Therapy Trial. Blood. 144(Supplement 1). 1053–1053. 2 indexed citations

Ljung, Rolf, Davide Matino, & Amy D. Shapiro. (2024). Recombinant factor IX Fc for the treatment of hemophilia B. European Journal Of Haematology. 112(5). 678–691. 2 indexed citations

Ay, Cihan, Maria Elisa Mancuso, Davide Matino, et al.. (2024). Noninterventional study assessing joint health in persons with hemophilia A after switching to turoctocog alfa pegol: design of pathfinderReal. Research and Practice in Thrombosis and Haemostasis. 8(2). 102363–102363. 1 indexed citations

Malec, Lynn, et al.. (2024). Unmet Needs, Factor Consumption, and Healthcare Resource Use Among People with Hemophilia a: Real-World Analysis of the Adelphi Hemophilia Disease Specific ProgrammeTM. Blood. 144(Supplement 1). 3973–3973.

Matino, Davide, Pierre Chelle, Shannon Jackson, et al.. (2023). OC 24.1 Effect of the Type of F9 Mutation on the Pharmacokinetic Profile of Patients with Hemophilia B Treated with Extended Half-Life FIX Concentrates. Research and Practice in Thrombosis and Haemostasis. 7. 100443–100443. 1 indexed citations

Rezende, Suely Meireles, Jan Voorberg, Maria Elisa Mancuso, et al.. (2023). Determinants of successful immune tolerance induction in hemophilia A: systematic review and meta-analysis. Research and Practice in Thrombosis and Haemostasis. 7(1). 100020–100020. 6 indexed citations

10.

Iorio, Alfonso, P Christoffersen, Davide Matino, et al.. (2023). Treatment switch to nonacog beta pegol factor IX in hemophilia B: A Canadian cost-consequence analysis based on real-world factor IX consumption and clinical outcomes. Research and Practice in Thrombosis and Haemostasis. 7(3). 100106–100106. 1 indexed citations

11.

Germini, Federico, Binu A. Philip, Omotola O Olasupo, et al.. (2022). Risk factors for bleeding in people living with hemophilia A and B treated with regular prophylaxis: A systematic review of the literature. Journal of Thrombosis and Haemostasis. 20(6). 1364–1375. 6 indexed citations

12.

Matino, Davide, Alfonso Iorio, Arun Keepanasseril, et al.. (2022). Switching to nonacog beta pegol in hemophilia B: Outcomes from a Canadian real‐world, multicenter, retrospective study. Research and Practice in Thrombosis and Haemostasis. 6(3). e12661–e12661. 5 indexed citations

13.

Germini, Federico, Man‐Chiu Poon, Arun Keepanasseril, et al.. (2020). Analysis of Hemophilia a Outcomes and Treatment Patterns Using Real-World Data from the Canadian Hemophilia Bleeding Disorder Registry. Blood. 136(Supplement 1). 37–38. 1 indexed citations

14.

Paes, Bosco, et al.. (2019). Inferior vena cava syndrome in neonates: An evidence‐based systematic review of the literature. Pediatric Blood & Cancer. 67(4). e28114–e28114. 1 indexed citations

15.

Malec, Lynn, Stacy E. Croteau, Michael U. Callaghan, et al.. (2019). Spontaneous Bleeding and Poor Bleeding Response with Extended Half-Life Factor IX Products: A Survey of Select US and Canadian Hemophilia Treatment Centers. Blood. 134(Supplement_1). 2407–2407. 6 indexed citations

16.

Romani, Rita, Giorgia Manni, Chiara Donati, et al.. (2018). S1P promotes migration, differentiation and immune regulatory activity in amniotic-fluid–derived stem cells. European Journal of Pharmacology. 833. 173–182. 18 indexed citations

17.

Matino, Davide, Chatree Chai‐Adisaksopha, & Alfonso Iorio. (2017). Systematic reviews of prognosis studies: a critical appraisal of five core clinical journals. PubMed. 1(1). 9–9. 6 indexed citations

18.

Mondanelli, Giada, Elisa Albini, Maria Teresa Pallotta, et al.. (2017). The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune Diabetes. Frontiers in Immunology. 8. 428–428. 29 indexed citations

19.

Romani, Rita, Francesca Fallarino, Mario Calvitti, et al.. (2015). Comparative proteomic analysis of two distinct stem-cell populations from human amniotic fluid. Molecular BioSystems. 11(6). 1622–1632. 5 indexed citations

20.

Nuti, Roberto, Marco Gargaro, Davide Matino, et al.. (2014). Ligand Binding and Functional Selectivity of l-Tryptophan Metabolites at the Mouse Aryl Hydrocarbon Receptor (mAhR). Journal of Chemical Information and Modeling. 54(12). 3373–3383. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact